Alessandro Allegra
- Molecular Biology top 5%
- Hematology top 1%
- Oncology top 2%
- Immunology top 5%
- Cancer Research top 2%
- Co-authors
- Caterina MusolinoSebastiano GangemiVanessa InnaoAndrea AlonciGiovanni PioggiaAlessandro TonacciDemetrio GeraceGiuseppa Penna
- Topics
- Multiple Myeloma Research and Treatments (35 papers)Chronic Lymphocytic Leukemia Research (19 papers)Acute Myeloid Leukemia Research (17 papers)
- Cited by
- HematologyCancer ResearchGenetics
- Journals
- SHILAP Revista de lepidopterologíaPLoS ONEInternational Journal of Molecular Sciences
- Partner nations
- ItalyUnited StatesRussia
In The Last Decade
Alessandro Allegra
246 papers receiving 4.9k citations
Peers
Comparison fields: 5 of 161
- Molecular Biology 1.9k
- Hematology 1.1k
- Oncology 985
- Immunology 710
- Cancer Research 677
Countries citing papers authored by Alessandro Allegra
This map shows the geographic impact of Alessandro Allegra's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alessandro Allegra with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alessandro Allegra more than expected).
Fields of papers citing papers by Alessandro Allegra
This network shows the impact of papers produced by Alessandro Allegra. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alessandro Allegra. The network helps show where Alessandro Allegra may publish in the future.
Co-authorship network of co-authors of Alessandro Allegra
This figure shows the co-authorship network connecting the top 25 collaborators of Alessandro Allegra. A scholar is included among the top collaborators of Alessandro Allegra based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alessandro Allegra. Alessandro Allegra is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 0 | |
| 7 | 0 | |
| 8 | 0 | |
| 9 | 4 | |
| 10 | 1 | |
| 11 | 11 | |
| 12 | 1 | |
| 13 | 3 | |
| 14 | 13 | |
| 15 | 5 | |
| 16 | 8 | |
| 17 | 12 | |
| 18 | 1 | |
| 19 | 10 | |
| 20 | 0 |
About Alessandro Allegra
Alessandro Allegra is a scholar working on Hematology, Genetics and Oncology, having authored 263 papers that have together received 5.0k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (35 papers), Chronic Lymphocytic Leukemia Research (19 papers) and Acute Myeloid Leukemia Research (17 papers). The work is most often cited by research in Hematology (1.1k citations), Cancer Research (677 citations) and Genetics (434 citations). Alessandro Allegra has collaborated with scholars based in Italy, United States and Russia. Frequent co-authors include Caterina Musolino, Sebastiano Gangemi, Vanessa Innao, Andrea Alonci, Giovanni Pioggia, Alessandro Tonacci, Demetrio Gerace, Giuseppa Penna, Michele Buemi and Sabina Russo. Their work appears in journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.